Nanoparticles show promise in treatment for triple-negative breast cancer, finds study
Date | 1st, Oct 2018 |
---|---|
Source | News Medical - Scientific News Websites |
DESCRIPTION
Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast cancer cells test negative for estrogen and progesterone receptors as well as HER2 receptors, genes that can play a role in the development of breast cancer.